<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diagnostic approach to the adult with cystic lung disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diagnostic approach to the adult with cystic lung disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Diagnostic approach to the adult with cystic lung disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anupam Kumar, MD, FCCP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert M Kotloff, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2773969508"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cystic lung diseases represent a heterogenous group of disorders that share in common the radiographic feature of multiple air-filled lucencies surrounded by discrete walls.</p><p>Conditions that are commonly referred to as diffuse cystic lung diseases include lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome (BHD), and lymphoid interstitial pneumonia (LIP), although the differential diagnosis can at times expand to encompass other extremely rare etiologies [<a href="#rid1">1,2</a>].</p><p>An approach to the diagnosis of diffuse cystic lung disease in adults will be reviewed here. The clinical manifestations, evaluation, and management of the individual causes of diffuse cystic lung disease are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis"</a> and  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/4361.html" rel="external">"Lymphoid interstitial pneumonia"</a>.)</p><p class="headingAnchor" id="H2761318205"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>Cysts and parenchymal lucencies that mimic cystic disease are typically defined by their appearance on high resolution computed tomography (CT)  (<a class="graphic graphic_table graphicRef113737" href="/z/d/graphic/113737.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H811520785"><span class="h2">Cysts</span><span class="headingEndMark"> — </span>A pulmonary cyst is defined as a "round parenchymal lucency or low-attenuating area with a well-defined interface with normal lung" [<a href="#rid3">3</a>]. (See <a class="local">'Parenchymal lucencies that may mimic cysts'</a> below.)</p><p class="headingAnchor" id="H1973100138"><span class="h2">Parenchymal lucencies that may mimic cysts</span><span class="headingEndMark"> — </span>Causes of lung parenchymal lucencies that may mimic cysts but do not fit the definition of true cystic lung disease include bullae, blebs, bronchiectasis, cavities, and pneumatoceles  (<a class="graphic graphic_table graphicRef113737" href="/z/d/graphic/113737.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emphysema</strong> – Areas of emphysema appear as polygonal or rounded low-attenuation areas. A central dot representing the pulmonary artery contained within the secondary pulmonary lobule can sometimes be seen [<a href="#rid3">3</a>]. Emphysematous areas, by definition, lack walls. However, this distinction may be difficult to discern, as interlobular septa surrounding emphysematous areas of lung may be misinterpreted as walls  (<a class="graphic graphic_diagnosticimage graphicRef112789 graphicRef112790" href="/z/d/graphic/112789.html" rel="external">image 1A-B</a>). Some forms of atypical emphysema present as lucencies that are indistinguishable from cysts. Conversely, in advanced stages, cystic lung disease may coalesce into larger areas of low attenuation that mimic emphysema  (<a class="graphic graphic_diagnosticimage graphicRef112789 graphicRef112790" href="/z/d/graphic/112789.html" rel="external">image 1A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bulla</strong> – The term bulla refers to a region of focal lucency that is &gt;1 cm in diameter, bounded by a thin wall (&lt;1 mm) and usually accompanied by adjacent emphysema. Bullae can be isolated and vary in size, sometimes filling the hemithorax  (<a class="graphic graphic_diagnosticimage graphicRef64765" href="/z/d/graphic/64765.html" rel="external">image 2</a> and <a class="graphic graphic_diagnosticimage graphicRef60307" href="/z/d/graphic/60307.html" rel="external">image 3</a>). A bleb is a type of subpleural bulla; the term bleb is now discouraged.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Honeycombing</strong> – Honeycombing represents the advanced, destructive phase of a variety of fibrotic lung disorders that lead to enlarged airspaces with thick fibrous walls. On high resolution CT, honeycombing appears as clustered hypolucent areas ranging in diameter from 0.3 to 1.0 cm (but occasionally as large as 2.5 cm), with well-defined, often thick walls  (<a class="graphic graphic_diagnosticimage graphicRef112791" href="/z/d/graphic/112791.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef77526" href="/z/d/graphic/77526.html" rel="external">image 5</a>) [<a href="#rid3">3</a>]. Honeycombing areas tend to be subpleural, stacked together in contiguous rows and sharing common walls. Associated radiologic features such as architectural distortion, subpleural reticular changes, and traction bronchiectasis further aid in distinguishing honeycombing due to pulmonary fibrosis from cystic lung disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchiectasis</strong> – Bronchiectatic cysts (also known as "cystic bronchiectasis") can be differentiated from cystic lung disease based on their continuity with an airway, tendency to form clusters  (<a class="graphic graphic_diagnosticimage graphicRef112792" href="/z/d/graphic/112792.html" rel="external">image 6</a>),<strong> </strong>and associated findings of tram lines and signet or Cabochon ring sign. (See  <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs", section on 'Bronchiectasis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cavitary lung disease</strong> – Pulmonary cavities are typically thick-walled (&gt;4 mm) gas-filled spaces often within an area of consolidation, mass, or nodule and may be filled with other contents in addition to air (eg, fluid, debris, mycetoma  (<a class="graphic graphic_diagnosticimage graphicRef112793" href="/z/d/graphic/112793.html" rel="external">image 7</a>)) [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumatoceles</strong> – Pneumatoceles are a type of thin-walled parenchymal cyst  (<a class="graphic graphic_diagnosticimage graphicRef113740" href="/z/d/graphic/113740.html" rel="external">image 8</a>). They most commonly arise in the setting of acute bacterial pneumonia, typically in children, but can also result from <em>Pneumocystis jirovecii</em> pneumonia  (<a class="graphic graphic_diagnosticimage graphicRef56620" href="/z/d/graphic/56620.html" rel="external">image 9</a>), chest trauma, or barotrauma from mechanical ventilation. While usually few in number, pneumatoceles can occasionally be numerous and in such cases, can be confused with the more diffuse cystic lung diseases. Notably, pneumatoceles are typically asymptomatic and often disappear following resolution of the inciting event.</p><p></p><p class="headingAnchor" id="H2837648319"><span class="h1">CAUSES OF CYSTIC LUNG DISEASE</span><span class="headingEndMark"> — </span>The majority of adults with cystic lung disease have one of four underlying diseases: lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome (BHD), or lymphoid interstitial pneumonia (LIP).</p><p>A separate category of cystic lung disease is associated with infectious etiologies; these patients typically present with acute onset of symptoms with fever and/or chills. Often the lung cysts are pneumatoceles that are caused by the infection (eg, coccidioidomycosis, hyperimmunoglobulinemia E syndrome, <em>Pneumocystis jirovecii</em>, recurrent respiratory papillomatosis, staphylococcal pneumonia) [<a href="#rid5">5-12</a>]. (See <a class="local">'Parenchymal lucencies that may mimic cysts'</a> above.)</p><p>Thin-wall cysts have been reported in 13 percent of 182 patients with nonfibrotic hypersensitivity pneumonitis (HP) [<a href="#rid13">13,14</a>]. The cysts measured 25 mm or less in diameter, ranged from 1 to 15 (average 4) in number, and had a random distribution. They are more common in fibrotic HP having been reported in 39 percent of patients in one study [<a href="#rid15">15</a>].</p><p>Occasionally, multiple pulmonary cysts may be the initial manifestation of metastatic cancer, such as squamous cell cancers (eg, head and neck, cervical) [<a href="#rid16">16</a>], invasive mucinous adenocarcinoma [<a href="#rid17">17</a>], and angiosarcoma  (<a class="graphic graphic_diagnosticimage graphicRef132336" href="/z/d/graphic/132336.html" rel="external">image 10</a>) [<a href="#rid18">18</a>].</p><p>Less common causes of diffuse cystic lung disease are listed in the table  (<a class="graphic graphic_table graphicRef113736" href="/z/d/graphic/113736.html" rel="external">table 2</a>). Examples include pulmonary amyloidosis [<a href="#rid19">19,20</a>], Sjögren's disease [<a href="#rid21">21</a>], light chain deposition disease [<a href="#rid22">22</a>], Ehlers Danlos syndrome type IV [<a href="#rid23">23</a>], fire-eater's lung (pneumatoceles) [<a href="#rid24">24,25</a>], lymphomatoid granulomatosis [<a href="#rid26">26</a>], neurofibromatosis [<a href="#rid27">27</a>], congenital pulmonary airway (cystic adenomatoid) malformation, smoking related small airways injury [<a href="#rid28">28</a>], and Proteus syndrome [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/5589.html" rel="external">"Overview of amyloidosis"</a> and  <a class="medical medical_review" href="/z/d/html/14920.html" rel="external">"Clinical manifestations and diagnosis of Ehlers-Danlos syndromes", section on 'Vascular EDS'</a> and  <a class="medical medical_review" href="/z/d/html/4324.html" rel="external">"Pulmonary lymphomatoid granulomatosis"</a> and  <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">"Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis", section on 'Other manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a> and  <a class="medical medical_review" href="/z/d/html/6303.html" rel="external">"Common causes of hoarseness in children", section on 'Papillomatosis'</a> and  <a class="medical medical_review" href="/z/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Proteus-like syndrome'</a> and  <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">"Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis", section on 'Other processes caused by inhalation of organic agents'</a>.)</p><p class="headingAnchor" id="H2884891779"><span class="h1">CLUES TO AN ETIOLOGY FOR CYSTIC LUNG DISEASE</span><span class="headingEndMark"> — </span>Patients with cystic lung disease may be asymptomatic, with radiographic abnormalities incidentally discovered on CT obtained for other reasons, or may present with respiratory symptoms, most commonly dyspnea or cough. Often, spontaneous pneumothorax is the presenting manifestation. However, none of these features is specific for a particular cystic lung disease. Importantly, the history, examination, and CT findings together guide the diagnostic evaluation.</p><p class="headingAnchor" id="H1839185358"><span class="h2">Clinical history</span><span class="headingEndMark"> — </span>A detailed clinical history can help to narrow the differential diagnosis of diffuse cystic lung disease. As examples, underlying systemic disease, such as tuberous sclerosis complex or Sjögren's disease (SjD), can direct attention to possible lymphangioleiomyomatosis or lymphoid interstitial pneumonia, respectively, while a family history of renal cancer or pneumothorax, might raise suspicion for Birt-Hogg-Dubé syndrome.</p><p class="headingAnchor" id="H1751465439"><span class="h3">Age, sex, and ethnicity</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphangioleiomyomatosis</strong> – Lymphangioleiomyomatosis (LAM) is a disorder that almost exclusively affects females; reported cases of LAM in males have, with one exception, occurred in association with tuberous sclerosis complex (TSC) [<a href="#rid30">30,31</a>]. Symptoms typically develop in the third and fourth decades of life [<a href="#rid32">32</a>]. In the United States, White people comprised 87 percent of patients enrolled in the National Heart, Lung, and Blood Institute LAM Registry, with Black or African Americans accounting for 6 percent, and Asian Americans accounting for 4 percent [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary Langerhans cell histiocytosis</strong> – Pulmonary Langerhans cell histiocytosis (PLCH) most commonly affects young adults, typically between the ages of 20 to 40. Sex distribution is equal to slightly female-predominant [<a href="#rid33">33</a>]. Reliable figures on racial distribution are lacking, though White individuals comprise the overwhelming majority of cases documented in the literature. (See  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birt-Hogg-Dubé syndrome</strong> – Lung cysts are seen in up to 84 percent of patients with Birt-Hogg-Dubé syndrome (BHD) and appear at a median age of 30 to 40 years [<a href="#rid34">34-36</a>]. Up to one-third of patients present with a spontaneous pneumothorax, with a median age of occurrence of 38 years [<a href="#rid37">37</a>]. However, the earliest and often overlooked manifestation of the disease is the development of cutaneous fibrofolliculomas on the face, neck, and chest that can be seen beginning in the third decade of life. There does not appear to be a particular sex predilection, and data on racial distribution are insufficient to allow comment. (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphoid interstitial pneumonia</strong> – Demographic information is not helpful in supporting a diagnosis of lymphoid interstitial pneumonia (LIP).</p><p></p><p class="headingAnchor" id="H3569512587"><span class="h3">Smoking</span><span class="headingEndMark"> — </span>The nearly universal association of PLCH with current or former cigarette smoking is well established [<a href="#rid33">33</a>]. Thus, PLCH is an exceedingly unlikely diagnosis in a never-smoker with cystic lung disease.</p><p>Among five patients with BHD syndrome, cigarette smoking was associated with more severe cystic changes and recurrent pneumothoraces [<a href="#rid38">38</a>], but in a large single family cohort, cigarette smoking had no correlation with the size or number of cysts [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H4180978719"><span class="h3">Family history</span><span class="headingEndMark"> — </span>A family history of lung disease or extrapulmonary findings is often present in patients with BHD and TSC-LAM, but not PLCH or LIP.</p><p>BHD is inherited in an autosomal dominant pattern and often affects multiple family members [<a href="#rid40">40</a>]. As such, eliciting a careful family history of spontaneous pneumothorax, lung cysts (often misdiagnosed as bulla or emphysema), renal neoplasms, and fibrofolliculomas can provide important clues to the diagnosis. In one study of 114 consecutive patients presenting with spontaneous pneumothorax, seven patients had a family history of pneumothorax and six of these were found to have BHD [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome"</a>.)</p><p>Patients with TSC-LAM may have a family history of intellectual disability, seizures, or cutaneous angiofibromas. (See  <a class="medical medical_review" href="/z/d/html/6175.html" rel="external">"Tuberous sclerosis complex: Clinical features"</a>.)</p><p class="headingAnchor" id="H2094196581"><span class="h2">Pulmonary manifestations</span><span class="headingEndMark"> — </span>The most common respiratory symptoms associated with these disorders are cough and dyspnea. Patients may also present with a spontaneous pneumothorax or pleural effusion.</p><p class="headingAnchor" id="H2187483136"><span class="h3">Pneumothorax</span><span class="headingEndMark"> — </span>Pneumothorax is a frequent manifestation of cystic lung disease, and may be the initial event calling attention to its presence. The prevalence of spontaneous pneumothorax is highest in LAM patients, in the range of 50 to 60 percent [<a href="#rid32">32,42</a>]. Reported frequencies of pneumothorax among patients with BHD and PLCH are 24 to 38 percent and 16 percent, respectively [<a href="#rid43">43,44</a>]. Pneumothorax is an uncommon manifestation of LIP, likely reflecting the paucity of cysts present in this disease.</p><p class="headingAnchor" id="H1140616031"><span class="h3">Pleural effusion</span><span class="headingEndMark"> — </span>Chylous effusions develop in roughly 10 percent of patients with LAM [<a href="#rid42">42</a>]. The combination of diffuse cystic lung disease on high resolution CT and chylous effusion is most often due to LAM, although lymphoma is a rare mimic of this combination. Pleural effusion is unusual in other forms of cystic lung diseases.</p><p class="headingAnchor" id="H1850374335"><span class="h2">Extrapulmonary manifestations</span><span class="headingEndMark"> — </span>Presence of extrapulmonary manifestations can provide important clues to distinguish between the various cystic lung diseases. Careful history (eg, abdominal swelling, polyuria, polydipsia) and examination of the skin (manifestations of TSC and BHD), together with imaging of the abdomen may identify extrapulmonary manifestations to support an underlying etiology for a specific cystic lung disorder.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>LAM</strong> – Manifestations associated with LAM include (see  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Nonpulmonary'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Renal angiomyolipomas (AMLs; approximately 30 percent)  (<a class="graphic graphic_diagnosticimage graphicRef112794" href="/z/d/graphic/112794.html" rel="external">image 11</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chylous ascites (10 percent)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lymphangioleiomyomas (up to 40 percent)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cutaneous manifestations of TSC, such as malar angiofibromas, hypopigmented macules (ash-leaf spots), Shagreen patches, and periungual fibromas</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic manifestations of TSC, including cognitive impairment, seizures, subependymal giant cell astrocytomas, cortical glioneuronal hamartomas, and subependymal nodules</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PLCH</strong> – Extrapulmonary involvement is seen in approximately 20 percent of patients with PLCH [<a href="#rid33">33</a>] (see  <a class="medical medical_review" href="/z/d/html/8385.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis", section on 'Clinical manifestations'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cystic bone lesions (7 percent)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arginine vasopressin disorder (formerly known as diabetes insipidus) (8 percent)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rarely, skin lesions (brown papules and eczema) and generalized lymphadenopathy [<a href="#rid33">33</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>BHD</strong> – In addition to pulmonary involvement, BHD is associated with renal and cutaneous manifestations:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Renal neoplasms: most commonly hybrid oncocytic tumors (50 percent), followed by chromophobe renal cell carcinomas (35 percent), clear cell renal cell carcinomas (9 percent), and renal oncocytomas (5 percent). (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome", section on 'Kidney tumors'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cutaneous lesions: 85 percent of patients have fibrofolliculomas  (<a class="graphic graphic_picture graphicRef112795" href="/z/d/graphic/112795.html" rel="external">picture 1</a>) [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome", section on 'Cutaneous lesions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>LIP</strong> – Although LIP is a disorder confined to the lungs, it is associated with a wide variety of underlying systemic autoimmune diseases and immunodeficiency in the majority of cases. Most common among these is SjD, present in 25 to 50 percent of LIP cases  (<a class="graphic graphic_diagnosticimage graphicRef113742" href="/z/d/graphic/113742.html" rel="external">image 12</a>) [<a href="#rid43">43,45</a>]. For this reason, patients presenting with cystic lung disease should be queried about the presence of dry eyes and dry mouth. Patients with immunodeficiency (eg, common variable immunodeficiency, HIV) often have a history of infection. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease"</a>.)</p><p></p><p class="headingAnchor" id="H2174985367"><span class="h1">RADIOGRAPHIC FEATURES</span><span class="headingEndMark"> — </span>High resolution CT (HRCT) of the chest is the cornerstone of the evaluation of patients with cystic lung disease. HRCT permits detailed characterization of the appearance and distribution of the cysts and identification of accompanying features. It is often sufficiently characteristic to suggest a presumptive diagnosis or, at the very least, to narrow the list of possibilities. Importantly, HRCT features are not pathognomonic and need to be interpreted in a clinical context so that further diagnostic testing can be selective.</p><p>The value of HRCT was highlighted in one retrospective study of HRCT performed in the evaluation of diffuse cystic lung disease [<a href="#rid46">46</a>]. A suspected radiographic diagnosis was correct in 70 to 80 percent of cases when HRCT was reviewed by radiologists or pulmonologists with expertise in cystic lung disease.</p><p class="headingAnchor" id="H2219086881"><span class="h2">Appearance and distribution of cysts</span><span class="headingEndMark"> — </span>Typical HRCT features of cysts are described for the following diseases:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphangioleiomyomatosis (LAM)</strong> – Parenchymal cysts associated with LAM are typically profuse and evenly distributed throughout both lungs  (<a class="graphic graphic_diagnosticimage graphicRef112796" href="/z/d/graphic/112796.html" rel="external">image 13</a>) [<a href="#rid47">47</a>]. They are thin-walled and round, display limited variability in size and shape, and lack internal structures such as vessels or septae.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary Langerhans cell histiocytosis (PLCH)</strong> – The cystic lesions of PLCH are irregularly and bizarrely shaped, have prominent walls, and tend to involve the upper lobes with relative sparing of the costophrenic angles  (<a class="graphic graphic_diagnosticimage graphicRef112797" href="/z/d/graphic/112797.html" rel="external">image 14</a>) [<a href="#rid48">48</a>]. Intervening lung may be normal or have multiple small nodules.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birt-Hogg-Dubé syndrome (BHD)</strong> – The cysts associated with BHD are thin-walled, often lentiform in shape (lens-shaped), basilar predominant, and distributed in subpleural regions and abutting the mediastinum  (<a class="graphic graphic_diagnosticimage graphicRef112798" href="/z/d/graphic/112798.html" rel="external">image 15</a>). Intervening lung is normal. A study employing quantitative methods to compare the CT features of LAM and BHD found significant differences in all parameters examined; BHD cysts were quantitatively less numerous, larger, and less circular in shape and demonstrated a lower-medial lung zone predominance [<a href="#rid47">47</a>]. Another study comparing CT features of BHD, LAM, and LIP found that patients with BHD were significantly more likely to have elliptical paramediastinal cysts or a disproportionate number of paramediastinal cysts [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphoid interstitial pneumonia (LIP)</strong> – Thin-walled cysts may be seen in the majority of patients with LIP. These cysts are typically few in number and are most often seen in areas of ground glass  (<a class="graphic graphic_diagnosticimage graphicRef112799" href="/z/d/graphic/112799.html" rel="external">image 16</a>) but may occur as an isolated finding [<a href="#rid50">50,51</a>]. They are often perivascular in distribution, vary in size ranging from 1 to 30 mm in diameter, and may have internal septae.</p><p></p><p class="headingAnchor" id="H420842587"><span class="h2">Nodules</span><span class="headingEndMark"> — </span>Multiple nodules should alert the physician to PLCH, although nodules can also be found in LIP and tuberous sclerosis complex (TSC)-LAM.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>PLCH</strong> – Radiographic abnormalities in PLCH typically begin as upper lobe nodules [<a href="#rid52">52</a>]. These nodules later cavitate ("cheerio sign") and ultimately form cystic lesions  (<a class="graphic graphic_diagnosticimage graphicRef112800" href="/z/d/graphic/112800.html" rel="external">image 17</a>) [<a href="#rid48">48,53</a>]. It is important to note that as the disease evolves, nodules and cystic lesions can coexist, and this combination may permit a radiographic diagnosis of PLCH with a high degree of confidence [<a href="#rid48">48,54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>LIP</strong> – Ill-defined centrilobular nodules and subpleural nodules can be seen in patients with LIP  (<a class="graphic graphic_diagnosticimage graphicRef113743" href="/z/d/graphic/113743.html" rel="external">image 18</a>) [<a href="#rid50">50,55</a>]. In patients with Sjögren's disease, the presence of nodules along with cysts should raise suspicion for concurrent lymphoma, light chain deposition disease, or amyloidosis [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>TSC-LAM</strong> – In some patients with TSC-LAM, multiple lung nodules accompany the cystic changes. These nodules usually represent multifocal micronodular pneumocyte hyperplasia (MMPH). The nodules of MMPH range in size from 2 to 14 mm and can be either solid or of ground glass attenuation. They tend to behave in an indolent fashion; in one series of 32 cases, there was no change in nodule number or size during a mean follow-up period of 2 +/- 1.1 years [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/z/d/html/4329.html" rel="external">"Tuberous sclerosis complex associated lymphangioleiomyomatosis in adults", section on 'Multifocal micronodular pneumocyte hyperplasia'</a>.)</p><p></p><p class="headingAnchor" id="H3501910186"><span class="h2">Ground glass opacities</span><span class="headingEndMark"> — </span>The combination of cysts and ground glass opacities is a common radiographic presentation of LIP; septal thickening and nodules may also be present. Ground glass opacities are usually not a feature of the other diffuse cystic lung diseases, although ground glass opacities have been described on CT scans of patients with PLCH and a concurrent smoking-related disorder, such as respiratory bronchiolitis/desquamative interstitial pneumonia [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/z/d/html/4319.html" rel="external">"Respiratory bronchiolitis-associated interstitial lung disease", section on 'Imaging'</a>.)</p><p class="headingAnchor" id="H579494924"><span class="h2">Pleural effusion</span><span class="headingEndMark"> — </span>Among the diffuse cystic lung diseases, pleural effusion is most likely to be due to LAM. Chylous pleural effusions occur in approximately 10 percent of patients with LAM and can be unilateral or bilateral  (<a class="graphic graphic_diagnosticimage graphicRef111639" href="/z/d/graphic/111639.html" rel="external">image 19</a>). Pleuritis from a systemic rheumatic disease is an uncommon cause of an effusion in LIP. Presence of pleural effusion in patients with LIP should also prompt evaluation for lymphoma, particularly when seen in association with large nodules and/or consolidative opacities [<a href="#rid59">59</a>]. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Chest CT'</a>.)</p><p class="headingAnchor" id="H2126107446"><span class="h2">Intra-abdominal features</span><span class="headingEndMark"> — </span>A number of intra-abdominal features can help determine the cause of diffuse cystic lung disease in patients with LAM or BHD.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphangioleiomyomatosis</strong> – LAM is associated with a number of intra-abdominal and pelvic features.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In particular, renal angiomyolipomas  (<a class="graphic graphic_diagnosticimage graphicRef112794" href="/z/d/graphic/112794.html" rel="external">image 11</a>) are demonstrated on abdominal imaging in 30 percent of individuals with sporadic LAM and 80 percent of those with TSC-LAM [<a href="#rid60">60</a>]. The imaging characteristics of renal AML and indications for percutaneous needle or surgical biopsy are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1684.html" rel="external">"Renal manifestations of tuberous sclerosis complex", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent2">Angiomyolipomas may also occasionally be seen within the liver  (<a class="graphic graphic_diagnosticimage graphicRef111640" href="/z/d/graphic/111640.html" rel="external">image 20</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lymphangioleiomyomas (fluid filled cystic masses) are another characteristic feature of LAM, occurring in approximately 16 percent. They are most often located in the retroperitoneum but may extend into, or arise in, the pelvis or mediastinum. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Lymphangioleiomyomas'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other findings on abdominal imaging in patients with LAM include ascites, thoracic duct dilatation, and lymphadenopathy [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birt-Hogg-Dubé</strong> – Renal neoplasms are found on abdominal imaging performed for screening purposes in up to 27 percent of patients with BHD [<a href="#rid61">61</a>]. These tumors are bilateral in approximately 50 percent of cases and multifocal in 65 percent. CT or magnetic resonance imaging (MRI) with contrast are the imaging procedures of choice. (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome", section on 'Kidney tumors'</a>.)</p><p></p><p class="headingAnchor" id="H2857910956"><span class="h1">DIAGNOSTIC APPROACH</span><span class="headingEndMark"> — </span>The majority of patients with diffuse cystic lung disease have one of four disorders: lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome (BHD), or lymphoid interstitial pneumonia (LIP). Other rare causes of diffuse cystic lung disease are listed in the table  (<a class="graphic graphic_table graphicRef113736" href="/z/d/graphic/113736.html" rel="external">table 2</a>). Our diagnostic approach starts with review of the clinical and radiographic features to narrow down the diagnostic possibilities, followed by focused testing to confirm the diagnosis  (<a class="graphic graphic_algorithm graphicRef113238" href="/z/d/graphic/113238.html" rel="external">algorithm 1</a>). The typical clinical, laboratory, and radiographic features and diagnostic criteria for each of the four main causes of diffuse cystic lung disease are summarized in the table, along with commonly employed confirmatory diagnostic studies  (<a class="graphic graphic_table graphicRef113738" href="/z/d/graphic/113738.html" rel="external">table 3</a>).</p><p>A characteristic constellation of clinical, laboratory, and radiographic features is often sufficient to establish a diagnosis without need for a surgical lung biopsy. In those cases where uncertainty remains and confirmation is essential for management (eg, progressive disease, anticipated initiation of <a class="drug drug_general" data-topicid="10329" href="/z/d/drug information/10329.html" rel="external">sirolimus</a> in LAM), histopathologic evaluation is typically necessary. In some cases, particularly in asymptomatic patients with normal lung function, a period of observation is also appropriate.</p><p>When pursuing a tissue biopsy, the least invasive method is selected. As an example, a lacrimal gland or lip biopsy may confirm a diagnosis of Sjögren's disease (SjD), a skin biopsy can establish a diagnosis of BHD, while bronchoalveolar lavage or transbronchial lung biopsy can provide a diagnosis in PLCH or LAM, respectively.</p><p class="headingAnchor" id="H2416120570"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>Focused laboratory testing can be helpful in suspected LIP, LAM, and BHD, as described in the following sections  (<a class="graphic graphic_algorithm graphicRef113238" href="/z/d/graphic/113238.html" rel="external">algorithm 1</a>). As the differentiation between cystic lung disease and emphysema can be difficult, we often obtain testing for alpha-1 antitrypsin deficiency, although the yield of such testing is low. (See  <a class="medical medical_review" href="/z/d/html/1464.html" rel="external">"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency", section on 'Laboratory testing'</a>.)</p><p>On occasions when the clinical and high resolution CT findings do not allow differentiation among the four main causes of cystic lung disease, some experts test more broadly and obtain testing for antinuclear antibody, anti-Ro/SSA and anti-La/SSB antibodies, rheumatoid factor, and vascular endothelial growth factor-D (VEGF-D), as well as genetic testing for the folliculin (<em>FLCN</em>) and tuberous sclerosis complex (TSC1 and TSC2) genes, and rarely for inheritable causes of bronchiectasis (eg, primary ciliary dyskinesia and cystic fibrosis). This approach is unproven and may be associated with increased cost to the patient.</p><p class="headingAnchor" id="H3872088376"><span class="h3">Serologic studies</span><span class="headingEndMark"> — </span>For patients with a known or suspected systemic rheumatic disease that might be associated with LIP, especially SjD, we usually obtain or review serologic studies such as the antinuclear antibody, anti-Ro/SSA and anti-La/SSB antibodies, and rheumatoid factor. (See  <a class="medical medical_review" href="/z/d/html/5593.html" rel="external">"Clinical manifestations of Sjögren’s disease: Extraglandular disease", section on 'Autoantibodies'</a>.)</p><p>If common variable immunodeficiency is suspected as a cause of LIP, serum immunoglobulin levels are measured or reviewed. Similarly, if a patient has risk factors for HIV infection, we test for HIV. (See  <a class="medical medical_review" href="/z/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults", section on 'Immunoglobulin levels'</a> and  <a class="medical medical_review" href="/z/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p>Serum levels of vascular endothelial growth factor-D (VEGF-D) are elevated above the upper limit of values in many patients with sporadic and TSC LAM, compared with healthy volunteers or individuals with other cystic lung disease [<a href="#rid62">62,63</a>]. A level of VEGF-D above 800 pg/mL is highly specific for LAM and, in a patient with compatible radiographic features, is considered diagnostic [<a href="#rid63">63-65</a>]. Notably, VEGF-D levels below this threshold do not exclude the diagnosis. This test is only available at specialized laboratories; its diagnostic value in LAM is described in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Vascular endothelial growth factor-D'</a>.)</p><p class="headingAnchor" id="H3098585450"><span class="h3">Genetic testing</span><span class="headingEndMark"> — </span>For patients without characteristic skin fibrofolliculomas or trichodiscomas, genetic testing may help with the diagnosis of BHD, which is caused by germline mutations in the <em>FLCN</em> gene. <em>FLCN</em> mutation analysis is available as a diagnostic test and detects mutations in 81 to 88 percent of patients with BHD [<a href="#rid37">37,40</a>]. However, deletion/duplication analysis (ie, copy number analysis) may be necessary, if <em>FLCN</em> gene sequence analysis does not identify a pathogenic variant. (See  <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">"Birt-Hogg-Dubé syndrome", section on 'Genetic testing'</a>.)</p><p>Genetic testing for tuberous sclerosis complex (<em>TSC1</em> and <em>TSC2</em>) genes, and for heritable causes of bronchiectasis (eg, primary ciliary dyskinesia and cystic fibrosis) is of unproven value but may be warranted in those in whom TSC or inheritable bronchiectasis is suspected. While loss of heterozygosity for the <em>TSC2</em> gene has been found in the urine and blood of patients with LAM, it may not be specific since it has also been found in patients with pulmonary Langerhans cell histiocytosis [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/z/d/html/2901.html" rel="external">"Genetic testing"</a>.)</p><p class="headingAnchor" id="H2933225811"><span class="h2">Bronchoscopy</span><span class="headingEndMark"> — </span>Bronchoscopy with bronchoalveolar lavage (BAL) and/or transbronchial lung biopsy (TBLB) may be helpful in selected patients, such as those with suspected LAM or PLCH and insufficient clinical or laboratory features to be confident in the diagnosis  (<a class="graphic graphic_algorithm graphicRef113238" href="/z/d/graphic/113238.html" rel="external">algorithm 1</a>). Bronchoscopic cryobiopsy has been successfully utilized to diagnose LAM, PLCH, and LIP, but there is insufficient experience with these disorders to comment on yield [<a href="#rid67">67-69</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphangioleiomyomatosis</strong> – TBLB with immunohistochemical staining for human melanoma black (HMB)-45 has been shown to identify LAM smooth muscle cells in 60 to 86 percent of cases, particularly when reviewed by a pathologist with expertise in LAM [<a href="#rid65">65,70-73</a>]. The yield from transbronchial biopsy may correlate with cyst profusion, low DLCO, and low FEV<sub>1</sub> [<a href="#rid65">65</a>]. BAL is not helpful in the diagnosis of LAM, except to exclude other processes. The role of biopsy in patents with suspected LAM is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Choosing transbronchial or surgical lung biopsy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary Langerhans cell histiocytosis</strong> – The presence of ≥5 percent CD1a-positive cells in BAL is considered strongly suggestive of PLCH but is poorly sensitive. BAL and TBLB together may yield a diagnosis in approximately 50 percent of patients [<a href="#rid70">70</a>]. Other patients will require video assisted surgical lung biopsy to confirm the presence of Langerhans cells positive for S-100 protein and CD1a. (See  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Flexible bronchoscopy'</a> and  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Lung biopsy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphoid interstitial pneumonia</strong> – BAL demonstrates lymphocytosis in approximately 30 percent of patients with LIP, but this is a nonspecific finding also seen in diseases such as sarcoidosis and hypersensitivity pneumonitis. Bronchoscopy is otherwise of limited value as TBLB does not provide an adequate sample size for the differentiation of interstitial pneumonias. (See  <a class="medical medical_review" href="/z/d/html/4361.html" rel="external">"Lymphoid interstitial pneumonia", section on 'Bronchoalveolar lavage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birt-Hogg-Dubé</strong> – There is no role for BAL or TBLB in suspected cases of BHD since there are no distinctive histologic features.</p><p></p><p class="headingAnchor" id="H3046239237"><span class="h2">Surgical lung biopsy</span><span class="headingEndMark"> — </span>The decision to proceed with a surgical biopsy (typically video-assisted thoracoscopic surgery [VATS]) is dependent on multiple factors including a suspected diagnosis with pathognomonic histopathology, the cystic burden, opportunity, need for therapy, and risk.</p><p>We typically proceed with surgical lung biopsy when the diagnosis remains in question following clinical, radiographic, and laboratory evaluation; when diagnostic confirmation is required in order to initiate therapy; and in the absence of contraindicating factors such as marginal lung function or significant pulmonary hypertension.</p><p>As the cystic changes in LIP tend to be nonprogressive, we are more likely to observe patients with known systemic rheumatic disease without a biopsy unless ground glass opacities or nodules are present, such that systemic glucocorticoids would be warranted for LIP, or the nodular opacities are concerning for lymphoma or infection.</p><p>Sometimes, surgical lung biopsy is obtained at the opportune time of surgical treatment for a pneumothorax (eg, patients with mild or nonprogressive disease).</p><p>VATS biopsy is generally definitive for diagnosis of LAM, PLCH, and LIP (or follicular bronchiolitis). In contrast, surgical lung biopsy is not appropriate in cases of confirmed BHD since there are no specific histologic features associated with cysts in this disorder. Certain rare causes of cystic lung disease may not be associated with specific histopathology (eg, neurofibromatosis). However, biopsy may be indicated, if an alternate or coexistent pathology is suspected (eg, LAM, lymphoma).</p><p>Less commonly, lung biopsy may be the best option to establish or exclude worrisome etiologies, such as metastatic cancer (eg, invasive adenocarcinoma, sarcoma, colorectal cancer), amyloidosis, light chain deposit disease, and non-Langerhans histiocytosis  (<a class="graphic graphic_table graphicRef113736" href="/z/d/graphic/113736.html" rel="external">table 2</a>).</p><p>The characteristic histopathologic features of LAM, PLCH, and LIP are described separately. (See  <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">"Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Definitive pathologic diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/4334.html" rel="external">"Pulmonary Langerhans cell histiocytosis", section on 'Lung biopsy'</a> and  <a class="medical medical_review" href="/z/d/html/4301.html" rel="external">"Interstitial lung disease associated with Sjögren's disease: Clinical manifestations, evaluation, and diagnosis", section on 'Lymphoid interstitial pneumonia'</a>.)</p><p class="headingAnchor" id="H1621643725"><span class="h2">Skin biopsy</span><span class="headingEndMark"> — </span>In a patient with compatible high resolution CT, confirmation of BHD is achieved by skin biopsy showing fibrofolliculomas, obviating the need for genetic testing for a folliculin gene<em> </em>mutation. (See <a class="local">'Genetic testing'</a> above.)</p><p class="headingAnchor" id="H2853359260"><span class="h1">PATIENT PERSPECTIVE TOPIC</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/z/d/html/131727.html" rel="external">"Patient perspective: Lymphangioleiomyomatosis (LAM)"</a>.)</p><p class="headingAnchor" id="H2603059136"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Cystic lung diseases represent a diverse group of disorders that share in common the radiologic feature of multiple air-filled lucencies surrounded by discrete walls (≤2 mm thickness). Diffuse cystic lung disease must be distinguished radiographically from emphysema, honeycombing, cystic bronchiectasis, pulmonary cavities, and pneumatoceles. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The four most common cystic lung diseases are lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), Birt-Hogg-Dubé syndrome (BHD), and lymphoid interstitial pneumonia (LIP). Other rare causes of cystic lung disease are listed in the table  (<a class="graphic graphic_table graphicRef113736" href="/z/d/graphic/113736.html" rel="external">table 2</a>). (See <a class="local">'Causes of cystic lung disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The manifestations of cystic lung disease are typically not specific for a particular disorder. Patients may present with cysts incidentally discovered on CT obtained for other reasons. Alternatively, they may present with nonspecific cough or dyspnea or with pneumothorax or a pleural effusion. (See <a class="local">'Clues to an etiology for cystic lung disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A detailed history with attention to demographics (age, sex, and ethnicity), smoking history, and family history (eg, features of tuberous sclerosis complex [TSC] or BHD) is important in the initial assessment. A careful search for extrapulmonary features, including cutaneous, pleural, and intra-abdominal manifestations, can provide insight into the diagnosis  (<a class="graphic graphic_table graphicRef113738" href="/z/d/graphic/113738.html" rel="external">table 3</a>). (See <a class="local">'Clues to an etiology for cystic lung disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>High resolution CT is an essential component of the evaluation process and often can differentiate between the various cystic lung diseases, especially when reviewed by an expert radiologist. (See <a class="local">'Radiographic features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Our diagnostic approach starts with review of the clinical and radiographic features to narrow down the diagnostic possibilities, followed by focused testing to confirm the diagnosis  (<a class="graphic graphic_algorithm graphicRef113238" href="/z/d/graphic/113238.html" rel="external">algorithm 1</a>). (See <a class="local">'Diagnostic approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory assessment can be used to establish a diagnosis of LAM (serum levels of vascular endothelial growth factor-D level ≥800 pg/mL) and can help identify patients with a systemic rheumatic disease that would increase the likelihood of LIP. For patients without characteristic skin fibrofolliculomas, genetic testing for folliculin (<em>FLCN</em>) gene variants may be indicated for patients with suspected BHD. (See <a class="local">'Laboratory testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When tissue confirmation is required in patients with suspected LAM or PLCH, bronchoscopy with transbronchial lung biopsy and appropriate immunostaining (ie, human melanoma black [HMB]-45 for LAM; CD1a antigen for PLCH) may be diagnostic in some cases. Bronchoalveolar lavage (BAL) showing CD1a antigen staining of 5 percent or more cells is considered supportive of PLCH. (See <a class="local">'Bronchoscopy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients without a clear diagnosis despite the above evaluation, particularly in the setting of progressive disease, surgical lung biopsy can be used to provide a definitive diagnosis of disorders associated with specific histopathology (LAM, PLCH, LIP). A lung biopsy is not indicated in disorders not associated with specific histopathology (eg, BHD) unless an alternate or co-existent process is suspected. (See <a class="local">'Surgical lung biopsy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin biopsy of a folliculoma may be diagnostic in BHD or prompt genetic testing for folliculin variants for confirmation. (See <a class="local">'Skin biopsy'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse Cystic Lung Disease. Part II. Am J Respir Crit Care Med 2015; 192:17.</a></li><li><a class="nounderline abstract_t">Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse Cystic Lung Disease. Part I. Am J Respir Crit Care Med 2015; 191:1354.</a></li><li><a class="nounderline abstract_t">Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697.</a></li><li><a class="nounderline abstract_t">Woodring JH, Fried AM, Chuang VP. Solitary cavities of the lung: diagnostic implications of cavity wall thickness. AJR Am J Roentgenol 1980; 135:1269.</a></li><li><a class="nounderline abstract_t">Venkata C, Ghafoor S, Venkateshiah SB. A 35-year-old man with recurrent pneumonias, eczema, coarse facial features, and cystic lung lesions. Chest 2008; 133:1026.</a></li><li><a class="nounderline abstract_t">Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 2007; 119:1234.</a></li><li><a class="nounderline abstract_t">Sadikot RT, Andrew AC, Wilson JD, Arnold AG. Recurrent respiratory papillomatosis with pulmonary cystic disease in a child, following maternal genital warts. Genitourin Med 1997; 73:63.</a></li><li><a class="nounderline abstract_t">Dancey DR, Chamberlain DW, Krajden M, et al. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 2000; 118:1210.</a></li><li><a class="nounderline abstract_t">Thompson GR 3rd. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med 2011; 32:754.</a></li><li><a class="nounderline abstract_t">Ooi A, Iyenger S, Barlow CW, Tsang GM. Aggressive Staphylococcal pneumonia: from multiple cavities to pneumatocole and giant bullae formation. Heart Lung Circ 2005; 14:115.</a></li><li><a class="nounderline abstract_t">Caksen H, Oztürk MK, Uzüm K, et al. Pulmonary complications in patients with staphylococcal sepsis. Pediatr Int 2000; 42:268.</a></li><li><a class="nounderline abstract_t">Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005; 41:583.</a></li><li><a class="nounderline abstract_t">Franquet T, Hansell DM, Senbanjo T, et al. Lung cysts in subacute hypersensitivity pneumonitis. J Comput Assist Tomogr 2003; 27:475.</a></li><li><a class="nounderline abstract_t">Lynch DA, Newell JD, Logan PM, et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165:807.</a></li><li><a class="nounderline abstract_t">Silva CI, Müller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246:288.</a></li><li><a class="nounderline abstract_t">Godwin JD, Webb WR, Savoca CJ, et al. Multiple, thin-walled cystic lesions of the lung. AJR Am J Roentgenol 1980; 135:593.</a></li><li><a class="nounderline abstract_t">Rogers C, Kent-Bramer J, Devaraj A, et al. Rapidly Progressive Cystic Lung Disease. Am J Respir Crit Care Med 2018; 198:264.</a></li><li><a class="nounderline abstract_t">Takimoto T, Osa A, Morita S, Abe K. Diffuse Pulmonary Cysts in Metastatic Angiosarcoma. Intern Med 2020; 59:457.</a></li><li><a class="nounderline abstract_t">Zamora AC, White DB, Sykes AM, et al. Amyloid-associated Cystic Lung Disease. Chest 2016; 149:1223.</a></li><li><a class="nounderline abstract_t">Avdeev SN, Merzhoeva ZM, Samsonova MV, et al. A 61-Year-Old Woman With Insidious Dyspnea and Diffuse Cystic Lung Disease. Chest 2021; 160:e199.</a></li><li><a class="nounderline abstract_t">Martínez-Balzano CD, Touray S, Kopec S. Cystic Lung Disease Among Patients With Sjögren Syndrome: Frequency, Natural History, and Associated Risk Factors. Chest 2016; 150:631.</a></li><li><a class="nounderline abstract_t">Omballi M, Ramaniuk A, Patel DC, Ataya A. A 29-Year-Old Woman With Cough, Dry Eyes, Pulmonary Cysts, and Nodules. Chest 2021; 160:e195.</a></li><li><a class="nounderline abstract_t">Dowton SB, Pincott S, Demmer L. Respiratory complications of Ehlers-Danlos syndrome type IV. Clin Genet 1996; 50:510.</a></li><li><a class="nounderline abstract_t">Franquet T, Gómez-Santos D, Giménez A, et al. Fire eater's pneumonia: radiographic and CT findings. J Comput Assist Tomogr 2000; 24:448.</a></li><li><a class="nounderline abstract_t">Gentina T, Tillie-Leblond I, Birolleau S, et al. Fire-eater's lung: seventeen cases and a review of the literature. Medicine (Baltimore) 2001; 80:291.</a></li><li><a class="nounderline abstract_t">Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: radiologic features and pathologic correlations. AJR Am J Roentgenol 2000; 175:1335.</a></li><li><a class="nounderline abstract_t">Ueda K, Honda O, Satoh Y, et al. Computed tomography (CT) findings in 88 neurofibromatosis 1 (NF1) patients: Prevalence rates and correlations of thoracic findings. Eur J Radiol 2015; 84:1191.</a></li><li><a class="nounderline abstract_t">Gupta N, Colby TV, Meyer CA, et al. Smoking-Related Diffuse Cystic Lung Disease. Chest 2018; 154:e31.</a></li><li><a class="nounderline abstract_t">Irion KL, Hocchegger B, Marchiori E, et al. Proteus syndrome: high-resolution CT and CT pulmonary densitovolumetry findings. J Thorac Imaging 2009; 24:45.</a></li><li><a class="nounderline abstract_t">Schiavina M, Di Scioscio V, Contini P, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007; 176:96.</a></li><li><a class="nounderline abstract_t">Adriaensen ME, Schaefer-Prokop CM, Duyndam DA, et al. Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex. Clin Radiol 2011; 66:625.</a></li><li><a class="nounderline abstract_t">Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006; 173:105.</a></li><li><a class="nounderline abstract_t">Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346:484.</a></li><li><a class="nounderline abstract_t">Schmidt LS, Linehan WM. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome. Nat Rev Urol 2015; 12:558.</a></li><li><a class="nounderline abstract_t">Marciniak SJ, Johnson SR. Pneumothorax and the biology of Birt-Hogg-Dubé syndrome. Thorax 2020; 75:442.</a></li><li><a class="nounderline abstract_t">Chu L, Luo Y, Chen H, et al. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome. Thorax 2020; 75:486.</a></li><li><a class="nounderline abstract_t">Toro JR, Pautler SE, Stewart L, et al. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. Am J Respir Crit Care Med 2007; 175:1044.</a></li><li><a class="nounderline abstract_t">Ayo DS, Aughenbaugh GL, Yi ES, et al. Cystic lung disease in Birt-Hogg-Dube syndrome. Chest 2007; 132:679.</a></li><li><a class="nounderline abstract_t">Skolnik K, Tsai WH, Dornan K, et al. Birt-Hogg-Dubé syndrome: a large single family cohort. Respir Res 2016; 17:22.</a></li><li><a class="nounderline abstract_t">Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008; 45:321.</a></li><li><a class="nounderline abstract_t">Torricelli E, Occhipinti M, Cavigli E, et al. The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome. Respiration 2019; 98:125.</a></li><li><a class="nounderline abstract_t">Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55:1052.</a></li><li><a class="nounderline abstract_t">Cha SI, Fessler MB, Cool CD, et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006; 28:364.</a></li><li><a class="nounderline abstract_t">Mendez JL, Nadrous HF, Vassallo R, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004; 125:1028.</a></li><li><a class="nounderline abstract_t">Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978; 88:616.</a></li><li><a class="nounderline abstract_t">Gupta N, Meraj R, Tanase D, et al. Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases. Eur Respir J 2015; 46:1196.</a></li><li><a class="nounderline abstract_t">Tobino K, Gunji Y, Kurihara M, et al. Characteristics of pulmonary cysts in Birt-Hogg-Dubé syndrome: thin-section CT findings of the chest in 12 patients. Eur J Radiol 2011; 77:403.</a></li><li><a class="nounderline abstract_t">Abbott GF, Rosado-de-Christenson ML, Franks TJ, et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographics 2004; 24:821.</a></li><li><a class="nounderline abstract_t">Escalon JG, Richards JC, Koelsch T, et al. Isolated Cystic Lung Disease: An Algorithmic Approach to Distinguishing Birt-Hogg-Dubé Syndrome, Lymphangioleiomyomatosis, and Lymphocytic Interstitial Pneumonia. AJR Am J Roentgenol 2019; 212:1260.</a></li><li><a class="nounderline abstract_t">Johkoh T, Müller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212:567.</a></li><li><a class="nounderline abstract_t">Silva CI, Flint JD, Levy RD, Müller NL. Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging 2006; 21:241.</a></li><li><a class="nounderline abstract_t">Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001; 25:630.</a></li><li><a class="nounderline abstract_t">Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989; 172:255.</a></li><li><a class="nounderline abstract_t">Kim HJ, Lee KS, Johkoh T, et al. Pulmonary Langerhans cell histiocytosis in adults: high-resolution CT-pathology comparisons and evolutional changes at CT. Eur Radiol 2011; 21:1406.</a></li><li><a class="nounderline abstract_t">Johkoh T, Ichikado K, Akira M, et al. Lymphocytic interstitial pneumonia: follow-up CT findings in 14 patients. J Thorac Imaging 2000; 15:162.</a></li><li><a class="nounderline abstract_t">Baqir M, Kluka EM, Aubry MC, et al. Amyloid-associated cystic lung disease in primary Sjögren's syndrome. Respir Med 2013; 107:616.</a></li><li><a class="nounderline abstract_t">Muzykewicz DA, Black ME, Muse V, et al. Multifocal micronodular pneumocyte hyperplasia: computed tomographic appearance and follow-up in tuberous sclerosis complex. J Comput Assist Tomogr 2012; 36:518.</a></li><li><a class="nounderline abstract_t">Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124:1199.</a></li><li><a class="nounderline abstract_t">Sirajuddin A, Raparia K, Lewis VA, et al. Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings. Radiographics 2016; 36:53.</a></li><li><a class="nounderline abstract_t">Avila NA, Kelly JA, Chu SC, et al. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology 2000; 216:147.</a></li><li><a class="nounderline abstract_t">Pavlovich CP, Grubb RL 3rd, Hurley K, et al. Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol 2005; 173:1482.</a></li><li><a class="nounderline abstract_t">Young LR, Vandyke R, Gulleman PM, et al. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest 2010; 138:674.</a></li><li><a class="nounderline abstract_t">McCormack FX, Gupta N, Finlay GR, et al. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. Am J Respir Crit Care Med 2016; 194:748.</a></li><li><a class="nounderline abstract_t">Hirose M, Matsumuro A, Arai T, et al. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis. PLoS One 2019; 14:e0212776.</a></li><li><a class="nounderline abstract_t">Gupta N, Finlay GA, Kotloff RM, et al. Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med 2017; 196:1337.</a></li><li><a class="nounderline abstract_t">Elia D, Torre O, Vasco C, et al. Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene. Chest 2022; 162:385.</a></li><li><a class="nounderline abstract_t">Gupta N, Wikenheiser-Brokamp K, Zander D, et al. Successful diagnosis of lymphangioleiomyomatosis with transbronchial lung cryobiopsy. Lymphology 2017; 50:154.</a></li><li><a class="nounderline abstract_t">Fruchter O, Fridel L, El Raouf BA, et al. Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy. Respirology 2014; 19:683.</a></li><li><a class="nounderline abstract_t">Bango-Álvarez A, Ariza-Prota M, Torres-Rivas H, et al. Transbronchial cryobiopsy in interstitial lung disease: experience in 106 cases - how to do it. ERJ Open Res 2017; 3.</a></li><li><a class="nounderline abstract_t">Harari S, Torre O, Cassandro R, et al. Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis. Respir Med 2012; 106:1286.</a></li><li><a class="nounderline abstract_t">Meraj R, Wikenheiser-Brokamp KA, Young LR, et al. Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis. Front Med 2012; 6:395.</a></li><li><a class="nounderline abstract_t">Koba T, Arai T, Kitaichi M, et al. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients. Respirology 2018; 23:331.</a></li><li><a class="nounderline abstract_t">Xu W, Cui H, Liu H, et al. The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis. BMC Pulm Med 2021; 21:146.</a></li></ol></div><div id="topicVersionRevision">Topic 112259 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25906201" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diffuse Cystic Lung Disease. Part II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25906089" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diffuse Cystic Lung Disease. Part I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18195376" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Fleischner Society: glossary of terms for thoracic imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6779538" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Solitary cavities of the lung: diagnostic implications of cavity wall thickness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18398125" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A 35-year-old man with recurrent pneumonias, eczema, coarse facial features, and cystic lung lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17335882" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Causes of death in hyper-IgE syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9155559" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Recurrent respiratory papillomatosis with pulmonary cystic disease in a child, following maternal genital warts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11035700" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22167403" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pulmonary coccidioidomycosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16363071" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Aggressive Staphylococcal pneumonia: from multiple cavities to pneumatocole and giant bullae formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10881583" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pulmonary complications in patients with staphylococcal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16080077" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12886127" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Lung cysts in subacute hypersensitivity pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7676971" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18096541" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6773384" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Multiple, thin-walled cystic lesions of the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29625015" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Rapidly Progressive Cystic Lung Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31534092" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Diffuse Pulmonary Cysts in Metastatic Angiosarcoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26513525" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Amyloid-associated Cystic Lung Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34366045" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A 61-Year-Old Woman With Insidious Dyspnea and Diffuse Cystic Lung Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27231156" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cystic Lung Disease Among Patients With Sjögren Syndrome: Frequency, Natural History, and Associated Risk Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34366044" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A 29-Year-Old Woman With Cough, Dry Eyes, Pulmonary Cysts, and Nodules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9147885" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Respiratory complications of Ehlers-Danlos syndrome type IV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10864084" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fire eater's pneumonia: radiographic and CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11552082" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Fire-eater's lung: seventeen cases and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11044036" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Lymphomatoid granulomatosis: radiologic features and pathologic correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25802206" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Computed tomography (CT) findings in 88 neurofibromatosis 1 (NF1) patients: Prevalence rates and correlations of thoracic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30080520" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Smoking-Related Diffuse Cystic Lung Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19242304" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Proteus syndrome: high-resolution CT and CT pulmonary densitovolumetry findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17431222" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21459371" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210669" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11844849" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26334087" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Molecular genetics and clinical features of Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32414881" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pneumothorax and the biology of Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32238524" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17322109" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17505035" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Cystic lung disease in Birt-Hogg-Dube syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26928018" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Birt-Hogg-Dubésyndrome: a large single family cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234728" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubésyndrome: a new series of 50 families and a review of published reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31266032" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-DubéSyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11083892" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical experience of lymphangioleiomyomatosis in the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16571614" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Lymphoid interstitial pneumonia: clinical features, associations and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15006964" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pneumothorax in pulmonary Langerhans cell histiocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/646244" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Lymphocytic interstitial pneumonitis. Review of 13 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26160866" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19782489" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Characteristics of pulmonary cysts in Birt-Hogg-Dubésyndrome: thin-section CT findings of the chest in 12 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15143231" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : From the archives of the AFIP: pulmonary Langerhans cell histiocytosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30888864" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Isolated Cystic Lung Disease: An Algorithmic Approach to Distinguishing Birt-Hogg-DubéSyndrome, Lymphangioleiomyomatosis, and Lymphocytic Interstitial Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10429719" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16915074" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11342775" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2787036" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Pulmonary histiocytosis X: evaluation with high-resolution CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21311888" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pulmonary Langerhans cell histiocytosis in adults: high-resolution CT-pathology comparisons and evolutional changes at CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10928607" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Lymphocytic interstitial pneumonia: follow-up CT findings in 14 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23402779" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Amyloid-associated cystic lung disease in primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22992599" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Multifocal micronodular pneumocyte hyperplasia: computed tomographic appearance and follow-up in tuberous sclerosis complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14555547" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26761531" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10887241" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Lymphangioleiomyomatosis: abdominopelvic CT and US findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15821464" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evaluation and management of renal tumors in the Birt-Hogg-Dubésyndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20382711" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27628078" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30818375" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29140122" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35231481" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30234253" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Successful diagnosis of lymphangioleiomyomatosis with transbronchial lung cryobiopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24750376" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28344982" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Transbronchial cryobiopsy in interstitial lung disease: experience in 106 cases - how to do it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22770823" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23224417" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28960664" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33941134" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
